-
Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH.
Am J Obstet Gynecol 2001;184:497-502. -
Repeatability of measurement of uterine artery pulsatility index using transvaginal color Doppler.
Papageorghiou AT, To MS, Yu CK, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:456-9. -
Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:441-9. -
First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH.
Obstet Gynecol 2001;98:608-11. -
Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation.
Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:583-6. -
Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks.
Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH.
Obstet Gynecol 2001;98:369-73. -
Trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18.
Sebire NJ, Fowler D, Roberts L, Mahmood S, Nicolaides KH.
Placenta 2000;21:584-6. -
Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia.
Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH.
BJOG 2000;107:795-7. -
First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.
Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH.
BJOG 2000;107:1265-70. -
Increased fetal erythroblasts in women who subsequently develop pre-eclampsia.
Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH.
Hum Reprod 2000;15:1624-8. -
One-stage screening for pregnancy complications by color doppler assessment of the uterine arteries at 23 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH.
Obstet Gynecol 2000;96:559-64. -
Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation.
Tul N, Spencer K, Noble P, Chan C, Nicolaides K.
Prenat Diagn 1999;19:1035-42. -
Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan.
Sherod C, Sebire NJ, Soares W, Snijders RJ, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;10:387-90. -
The maternal insulin-like growth factor (IGF) and IGF binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP, Langford KS, Jones JS, Noble P, Westwood m, White A, Nicolaides KH.
J Clin Endocrinol Metab 1997;82:287-92. -
Placental mRNA expression of alpha and beta human chorionic gonadotrophin in early trisomy 18 pregnancies.
Brizot ML, Jauniaux E, Mckie AT, Farzaneh F, Nicolaides KH.
Mol Hum Reprod 1996;2:463-5. -
Superovulation, IGFBP-1 and birth weight.
Johnson MR, Irvine R, Hills F, Bolton VN, Abbas AA, Brooks AA, Allman AC, Chard T, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:193-5. -
Cardiac defects in 1st-trimester fetuses with trisomy 18.
Hyett JA, Moscoso G, Nicolaides KH.
Fetal Diagn Ther 1995;10:381-6. -
Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation: arterial, intracardiac and venous blood flow velocity studies.
Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides KH.
Circulation 1995;91:129-38.